{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fnew-hiv-data-in-la-art-ULGYIgOt","width":444,"version":"1.0","type":"rich","title":"Studies of LA ART in People With Adherence Challenges or Viremia","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/c856ba14-1832-4e55-a83a-5d3886d6ad47/6298-contemporary-pod4-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/26c2e4a7-4987-47c6-8010-d0a6b14334bd\" height=\"200\" width=\"100%\" title=\"Studies of LA ART in People With Adherence Challenges or Viremia\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Jonathan Appelbaum, MD, FACP, AAHIVS, discuss the newest data supporting LA ART use in people with adherence challenges or viremia, including the LATITUDE study, updates to the Ward 86 cohort, and the CARES study."}